The Trump administration will require all 50 states to explain their plans to revalidate some of their Medicaid providers in ...
Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...
Some health insurers are pushing back against a new program that will allow Medicare beneficiaries to pay $50 per month for ...
Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.
The Trump administration has extended a short-term program that offers Medicare coverage for weight loss drugs such as Novo’s (NVO) Wegovy and Lilly’s (LLY) Zepbound after leading health insurers ...
In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...
CMS pitches hospital pay with a 2.4% increase and launches a mandatory joint replacement payment model starting fiscal year 2027.
CMS greenlights more than 150 digital health companies for its ACCESS experiment, a new program for tech-backed chronic care ...
The Trump administration is putting all 50 states on notice.
Agency plans to ask states to "own" the problem of healthcare fraud ...